243
Views
3
CrossRef citations to date
0
Altmetric
Research Articles

Sustained delivery of prilocaine and lidocaine using depot microemulsion system: in vitro, ex vivo and in vivo animal studies

, , , & ORCID Icon
Pages 264-271 | Received 16 Oct 2019, Accepted 09 Jan 2020, Published online: 30 Jan 2020

References

  • Rawal N, Axelsson K, Hylander J, et al. Postoperative patient-controlled local anesthetic administration at home. Anesth Analg. 1998;86(1):86–89.
  • Tadicherla S, Berman B. Percutaneous dermal drug delivery for local pain control. Ther Clin Risk Manag. 2006;2(1):99–105.
  • Huang W, Vidimos A. Topical anesthetics in dermatology. J Am Acad Dermatol. 2000;43(2):286–298.
  • Wheatley GH, III, Rosenbaum DH, Paul MC, et al. Improved pain management outcomes with continuous infusion of a local anesthetic after thoracotomy. J Thorac Cardiovasc Surg. 2005;130(2):464–468.
  • Ong CK-S, Lirk P, Seymour RA, et al. The efficacy of preemptive analgesia for acute postoperative pain management: a meta-analysis. Anesth Analg. 2005;100(3):757–773.
  • Morris R, McKay W, Mushlin P. Comparison of pain associated with intradermal and subcutaneous infiltration with various local anesthetic solutions. Anesth Analg. 1987;66(11):1180–1182.
  • Palmon SC, Lloyd AT, Kirsch JR. The effect of needle gauge and lidocaine pH on pain during intradermal injection. Anesth Analg. 1998;86(2):379–381.
  • Howe NR, Williams JM. Pain of injection and duration of anesthesia for intradermal infiltration of lidocaine, bupivacaine, and etidocaine. J Dermatol Surg Oncol. 1994;20(7):459–464.
  • Ruetsch YA, Boni T, Borgeat A. From cocaine to ropivacaine: the history of local anesthetic drugs. CTMC. 2001;1(3):175–182.
  • Altman RS, Smith-Coggins R, Ampel LL. Local anesthetics. Ann Emerg Med. 1985;14(12):1209–1217.
  • Covino B. The pharmacology of local anesthetic agents. Br J Anaesth. 1986;58:701–716.
  • Tetzlaff JE. The pharmacology of local anesthetics. Anesthesiol Clin North Am. 2000;18(2):217–233.
  • Zink W, Bohl JR, Hacke N, et al. The long term myotoxic effects of bupivacaine and ropivacaine after continuous peripheral nerve blocks. Anesth Analg. 2005;101(2):548–554.
  • Barletta JF. Clinical and economic burden of opioid use for postsurgical pain: focus on ventilatory impairment and ileus. Pharmacotherapy. 2012;32(9pt2):12S–18S.
  • Ilfeld BM. Continuous peripheral nerve blocks: a review of the published evidence. Anesth Analg. 2011;113(4):904–925.
  • Kerr DR, Kohan L. Local infiltration analgesia: a technique for the control of acute postoperative pain following knee and hip surgery: a case study of 325 patients. Acta Orthopaedica. 2008;79(2):174–183.
  • Tobe M, Obata H, Suto T, et al. Long-term effect of sciatic nerve block with slow-release lidocaine in a rat model of postoperative pain. Anesthesiology. 2010;112(6):1473–1481.
  • Maniadakis N, Gray A. The economic burden of back pain in the UK. Pain. 2000;84(1):95–103.
  • Kumari AK, Harichandrakumar K, Das L, et al. Physical and psychosocial burden due to lymphatic filariasis as perceived by patients and medical experts. Trop Med Int Health. 2005;10(6):567–573.
  • Pöpping DM, Elia N, Marret E, et al. Clonidine as an adjuvant to local anesthetics for peripheral nerve and plexus blocksA meta-analysis of randomized trials. Anesthesiology. 2009;111(2):406–415.
  • Culebras X, Van Gessel E, Hoffmeyer P, et al. Clonidine combined with a long acting local anesthetic does not prolong postoperative analgesia after brachial plexus block but does induce hemodynamic changes. Anesth Analg. 2001;92(1):199–204.
  • Myers RR, Heckman HM. Effects of local anesthesia on nerve blood flow: studies using lidocaine with and without epinephrine. Anesthesiology. 1989;71(5):757–762.
  • Stewart JH, Cole GW, Klein JA. Neutralized lidocaine with epinephrine for local anesthesia. J Dermatol Surg Oncol. 1989;15(10):1081–1088.
  • Colombo G, Padera R, Langer R, et al. Prolonged duration local anesthesia with lipid–protein–sugar particles containing bupivacaine and dexamethasone. J Biomed Mater Res. 2005;75(2):458–464.
  • Holte K, Werner MU, Lacouture PG, et al. Dexamethasone prolongs local analgesia after subcutaneous infiltration of bupivacaine microcapsules in human volunteers. Anesthesiology. 2002;96(6):1331–1335.
  • Kopacz DJ, Lacouture PG, Wu D, et al. The dose response and effects of dexamethasone on bupivacaine microcapsules for intercostal blockade (T9 to T11) in healthy volunteers. Anesth Analg. 2003;96(2):576–582.
  • Gesztes A, Mezei M. Topical anesthesia of the skin by liposome-encapsulated tetracaine. Anesth Analg. 1988;67(11):1079–1081.
  • Gabriel RA, Ilfeld BM. An updated review on liposome bupivacaine. Curr Anesthesiol Rep. 2019;9(3):1–5.
  • Zhao X, Gao Y, Tang X, et al. Development and evaluation of ropivacaine loaded poly (lactic-co-glycolic acid) microspheres with low burst release. Curr Drug Deliv. 2019;16(6):490–499.
  • Kohane DS, Smith SE, Louis DN, et al. Prolonged duration local anesthesia from tetrodotoxin-enhanced local anesthetic microspheres. Pain. 2003;104(1):415–421.
  • Pignatello R, Basile L, Puglisi G. Chitosan glutamate hydrogels with local anesthetic activity for buccal application. Drug Delivery. 2009;16(3):176–181.
  • de Araujo DR, da Silva DC, Barbosa RM, et al. Strategies for delivering local anesthetics to the skin: focus on liposomes, solid lipid nanoparticles, hydrogels and patches. Expert Opin Drug Deliv. 2013;10(11):1551–1563.
  • Kevadiya BD, Joshi GV, Mody HM, et al. Biopolymer–clay hydrogel composites as drug carrier: host–guest intercalation and in vitro release study of lidocaine hydrochloride. Appl Clay Sci. 2011;52(4):364–367.
  • Grillo R, de Melo NF, de Araújo DR, et al. Polymeric alginate nanoparticles containing the local anesthetic bupivacaine. J Drug Target. 2010;18(9):688–699.
  • Beiranvand S, Eatemadi A, Karimi A. New updates pertaining to drug delivery of local anesthetics in particular bupivacaine using lipid nanoparticles. Nanoscale Res Lett. 2016;11(1):307–315.
  • Üstündağ Okur N, Ege MA, Karasulu HY. Preparation and characterization of naproxen loaded microemulsion formulations for dermal application. Int J Pharm. 2014;4(4):33–42.
  • Üstündağ Okur N, Yavaşoğlu A, Karasulu HY. Preparation and evaluation of microemulsion formulations of naproxen for dermal delivery. Chem Pharm Bull. 2014;62(2):135–143.
  • Üstündağ Okur N, Çağlar EŞ, Arpa MD, et al. Preparation and evaluation of novel microemulsion-based hydrogels for dermal delivery of benzocaine. Pharm Dev Technol. 2017;22(4):500–510.
  • Changez M, Chander J, Dinda AK. Transdermal permeation of tetracaine hydrochloride by lecithin microemulsion: in vivo. Colloids Surf B: Biointerfaces. 2006;48(1):58–66.
  • Pandey SS, Maulvi FA, Patel PS, et al. Cyclosporine laden tailored microemulsion-gel depot for effective treatment of psoriasis: in vitro and in vivo studies. Colloids Surf B: Biointerfaces. 2020;186:110681.
  • Rees GD, Robinson BH. Microemulsions and organogels: properties and novel applications. Adv Mater. 1993;5(9):608–619.
  • Klier J, Tucker CJ, Kalantar TH, et al. Properties and applications of microemulsions. Adv Mater. 2000;12(23):1751–1757.
  • Giustini M, Murgia S, Palazzo G. Does the Schulman’s titration of microemulsions really provide meaningful parameters? Langmuir. 2004;20(18):7381–7384.
  • Ranch K, Patel H, Chavda L, et al. Development of in situ ophthalmic gel of dexamethasone sodium phosphate and chloramphenicol: a viable alternative to conventional eye drops. J Appl Pharm Sci. 2017;7:101–108.
  • Ranch KM, Maulvi FA, Naik MJ, et al. Optimization of a novel in situ gel for sustained ocular drug delivery using Box-Behnken design: in vitro, ex vivo, in vivo and human studies. Int J Pharm. 2019;554:264–275.
  • Maulvi FA, Patil RJ, Desai AR, et al. Effect of gold nanoparticles on timolol uptake and its release kinetics from contact lenses: in vitro and in vivo evaluation. Acta Biomaterialia. 2019;86:350–362.
  • Desai AR, Maulvi FA, Pandya MM, et al. Co-delivery of timolol and hyaluronic acid from semi-circular ring-implanted contact lenses for the treatment of glaucoma: in vitro and in vivo evaluation. Biomater Sci. 2018;6(6):1580–1591.
  • Mandal S, Mandal SS. Research paper microemulsion drug delivery system: a platform for improving dissolution rate of poorly water soluble drug. Int J Pharm Sci Nanotech. 2011;3(4):1214–1219.
  • Sroka-Markovic J, Johansson L, Andersson MB, et al. Development of an HPLC method for determination of related impurities in prilocaine substance. Chromatographia. 2012;75(7-8):329–336.
  • Storms ML, Stewart J. Stability-indicating HPLC assays for the determination of prilocaine and procaine drug combinations. J Pharm Biomed Anal. 2002;30(1):49–58.
  • Gebauer MG, McClure AF, Vlahakis TL. Stability indicating HPLC method for the estimation of oxycodone and lidocaine in rectal gel. Int J Pharm. 2001;223(1-2):49–54.
  • Malenovic A, Medenica M, Ivanovic D, et al. Development and validation of RP–HPLC method for cetrimonium bromide and lidocaine determination. Farmaco. 2005;60(2):157–161.
  • Shukla JB, Patel SJ. Formulation and evaluation of self micro emulsifying system of candesartan cilexetil. Int J Pharm Pharm Sci. 2010;2(4):143–146.
  • Skelly JP, Shah VP, Maibach HI, et al. FDA and AAPS report of the workshop on principles and practices of in vitro percutaneous penetration studies: relevance to bioavailability and bioequivalence. Pharm Res. 1987;04(3):265–267.
  • Flynn GL, Shah VP, Tenjarla SN, et al. Assessment of value and applications of in vitro testing of topical dermatological drug products. Pharm Res. 1999;16(9):1325–1330.
  • Lin Y-H, Tsai M-J, Fang Y-P, et al. Microemulsion formulation design and evaluation for hydrophobic compound: catechin topical application. Colloids Surf B: Biointerfaces. 2018;161:121–128.
  • Phillips L, II, Steinberg M, Maibach HI, et al. A comparison of rabbit and human skin response to certain irritants. Toxicol Appl Pharmacol. 1972;21(3):369–382.
  • Robinson MK, Osborne R, Perkins MA. In vitro and human testing strategies for skin irritation. Ann N Y Acad Sci. 2006;919(1):192–204.
  • Gfeller W, Kobel W, Seifert G. Overview of animal test methods for skin irritation. Food Chem Toxicol. 1985;23(2):165–168.
  • Sharma G, Kamboj S, Thakur K, et al. Delivery of thermoresponsive-tailored mixed micellar nanogel of lidocaine and prilocaine with improved dermatokinetic profile and therapeutic efficacy in topical anaesthesia. AAPS PharmSciTech. 2017;18(3):790–802.
  • Berge O-G, Garcia-Cabrera I, Hole K. Response latencies in the tail-flick test depend on tail skin temperature. Neurosci Lett. 1988;86(3):284–288.
  • Üstündağ Okur N, Filippousi M, Okur ME, et al. A novel approach for skin infections: controlled release topical mats of poly (lactic acid)/poly (ethylene succinate) blends containing Voriconazole. J Drug Deliv Sci Technol. 2018;46:74–86.
  • Üstündağ Okur N, Caglar EŞ, Pekcan AN, et al. Preparation, optimization and in vivo anti-inflammatory evaluation of hydroquinone loaded microemulsion formulations for melasma treatment. Marmara Pharm J. 2019;23(4):662–670.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.